Anyone who has watched Better Call Saul or Frasier is familiar with the spinoff concept, in which characters from an existing series branch off in a new show with a different story line. It works sort of the same way in corporate America with stock spinoffs, when firms split off a part of their business into a new, publicly traded company, usually via a tax-free distribution of the stock to shareholders of the original firm. The idea: Capitalize on a sum-of-the parts strategy, in which an undervalued business unlocks value under a new, simplified structure.
Stock spinoffs had a strong 2022, although momentum has slowed some this year. Last year, U.S. companies announced 44 spinoffs and completed 20, totaling $61 billion in market value, according to Goldman Sachs. So far this year, through mid July, nine U.S. spinoffs have been completed, according to financial information provider Dealogic.
In theory, stock spinoffs should be rewarding. Managers of the new company are unfettered by the old organizational chart and are often motivated by performance incentives in a way that was impossible in a bigger company. And the market may assign a higher valuation to businesses that are less complex and easier to understand, whereas conglomerates can be penalized.
Sign up for Kiplinger’s Free E-Newsletters
Profit and prosper with the best of expert advice on investing, taxes, retirement, personal finance and more – straight to your e-mail.
Profit and prosper with the best of expert advice – straight to your e-mail.
In truth, performance is mixed. GE HealthCare Technologies (GEHC) is up 39% since it began trading on January 4. But ZimVie (ZIMV), a dental and spinal treatment offshoot of medical-devices giant Zimmer Biomet (ZBH), has lost 64% of its stock value since March 2022. “Spinoffs are not a sure bet,” says Jim Osman, founder and chief executive of The Edge Group, a firm specializing in fundamental analysis of spinoffs and other special situations.
Yet, he says, because spinoffs are smaller firms that are under-followed by analysts, investors have more chances to uncover index-beating returns. And spinoffs can be bargains. In a spinoff distribution to parent-company shareholders, “investors gain these shares by default and sell them in the open market pretty much immediately, often making them cheap companies that no one is looking at,” says Osman. “It’s at this point where X marks the spot and you should start digging.”
Keep an eye out for these upcoming stock spinoffs
A number of high-profile spinoffs are expected later this year. Osman likes the chances for a few and suggests buying the parent company, pre-spinoff. Among them are Dow Jones stock 3M (MMM, $112), which will spin off its healthcare division. The new company will be focused on wound care, healthcare IT, oral care and filtration products used in the biopharma industry.
Danaher (DHR, $255) is shifting toward becoming a pure healthcare stock, so it is spinning off its Environmental and Applied Solutions division, with businesses aimed at protecting resources, including global food and water supplies.
Kellogg (K, $67) will split in two, separating its snack and plant-based food business (including Cheez-It and MorningStar Farms) from its North American cereal unit (Frosted Flakes, Special K).
For a diverse portfolio of companies that have already been spun off, consider the exchange-traded fund Invesco S&P Spin-Off (CSD, $60), with an expense ratio of 0.65%. The portfolio adds spinoffs with at least $1 billion in market value and holds them for four years. It uses a modified market-cap weighting, which skews the portfolio a bit toward larger holdings without allowing assets to concentrate in only the biggest names. The fund’s one-year gain of 10.6% ranks it within the top 21% of mid-cap blend funds.
Note: This item first appeared in Kiplinger’s Personal Finance Magazine, a monthly, trustworthy source of advice and guidance. Subscribe to help you make more money and keep more of the money you make here.
